ALEISHA COLLINS: Open Payments
NPI 1457880627 · HUNTINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 53 payments from 18 companies in 2025. Trend: 2023 $911 · 2024 $1,052 · 2025 $978
Food & beverage: $978
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $331 |
| AstraZeneca Pharmaceuticals LP | 6 | $194 |
| Astellas Pharma US Inc | 3 | $82 |
| Abbott Laboratories | 3 | $65 |
| Novo Nordisk Inc | 2 | $38 |
| PFIZER INC. | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $24 |
| Lundbeck LLC | 1 | $23 |
| Dexcom, Inc. | 1 | $22 |
| Tonix Medicines, Inc. | 1 | $22 |
Products named: VRAYLAR, FARXIGA, QULIPTA, Veozah, UBRELVY, FREESTYLE LIBRE 3, BREZTRI, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
